SCHEMBL9531609

SCHEMBL9531609

CCCc1c(Cl)n(C(C)CC)c(=O)n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.54
AGTR1 P30556 2/20 0.52
AGTR2 P50052 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9555120 0.94 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9538303 0.92 AGTR1 (0.48) PPARGAGTR1AGTR2
SCHEMBL9531966 0.92 PPARG (0.54) PPARGAGTR1AGTR2
SCHEMBL9555467 0.90 PPARG (0.52) PPARG
SCHEMBL9530674 0.90 PPARG (0.52) PPARGAGTR1AGTR2
SCHEMBL9554529 0.89 PPARG (0.52) PPARGAGTR1AGTR2
SCHEMBL9553994 0.89 PPARG (0.51) PPARGAGTR1AGTR2
SCHEMBL9553525 0.88 PPARG (0.50) PPARGAGTR1AGTR2
SCHEMBL9554170 0.88 PPARG (0.50) PPARGAGTR1AGTR2
SCHEMBL9554103 0.87 PPARG (0.52) PPARGAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed